Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study Meeting Abstract

  

Authors:	Jhawer, M. P.; Kindler, H. L.; Wainberg, Z. A.; Hecht, J. R.; Kerr, R. O.; Ford, J. M.; Henderson, C.; Mueller, T.; Keer, H. N.; Shah, M. A.
Abstract Title:	Preliminary activity of XL880, a dual MET/VEGFR2 inhibitor, in MET amplified poorly differentiated gastric cancer (PDGC): Interim results of a multicenter phase II study
Meeting Title:	44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	15 Suppl.
Meeting Dates:	2008 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-05-20
Start Page:	231s
Language:	English
ACCESSION:	WOS:000208457401683
DOI:	10.1200/jco.2008.26.15_suppl.4572
PROVIDER:	wos
Notes:	Meeting Abstract: 4572 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129825